CD4+CD25+ T cells alloactivated ex vivo by IL-2 or IL-4 become potent alloantigen-specific inhibitors of rejection with different phenotypes, suggesting separate pathways of activation by Th1 and Th2 responses
- Resource Type
- Article
- Source
- In
Blood 8 January 2009 113(2):479-487 - Subject
- Language
- ISSN
- 0006-4971